<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="pharmaceutical-sciences" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Open Science Publishers LLP</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">228</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">https://doi.org/10.31782/IJMPS.2023.13502</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmaceutical Sciences</subject></subj-group></article-categories><title-group><article-title>Recent Advancements in the Pharmacotherapeutic Perspectives of Potential Anti-Viral Agents&#13;
&#13;
__ampersandsignnbsp;&#13;
&#13;
__ampersandsignnbsp;&#13;
&#13;
__ampersandsignnbsp;&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shambharkar</surname><given-names>Prachi</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thakre</surname><given-names>Kalyani</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chacherkar</surname><given-names>Pooja</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>11</day><month>05</month><year>2023</year></pub-date><volume>)</volume><issue/><fpage>10</fpage><lpage>13</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>In latest years, extensive outburst of abundant infectious ailments across the world has created chaos between the populations. Chiefly, the residents in the tropical and sub-tropical areas are concerned by these virulent pathogens. In spite of the development in significant elementary acquaintance regarding a variety of pathogens, the existing chemotherapy is still unacceptable as a result of imperfect effectiveness, long-term action, high cost, and unwanted side-effects. Natural products and synthetic compounds have been found to express numerous pharmacological activities. The present review article focuses on the therapeutic perspectives of chalcone based natural compounds in exhibiting anti-viral activity against rhino virus, human immunodeficiency virus (HIV), influenza virus, polio virus, dengue virus, and tobacco mosaic virus (TMV) by modulating vital therapeutic targets like HIV-1 protease, DEN-1 NS3 protease, and neuraminidase. These natural compounds serve as interesting leads for synthetic drug fabrication by various drug design, drug discovery, and drug development approaches as well as structure activity relationships (SARs) predictions. These compounds from nature may serve as templates for further exploration of molecular targets, structural biology, mechanism of actions (MOAs), etc.&#13;
</p></abstract><kwd-group><kwd>Anti-viral</kwd><kwd> HIV</kwd><kwd> Polio</kwd><kwd> Rhino</kwd><kwd> Dengue</kwd><kwd> Influenza</kwd></kwd-group></article-meta></front></article>
